Who are Selective serotonin reuptake inhibitors's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Lexapro, Zoloft, Prozac, Track A, sertraline fluvoxamine, Citalopram HCl.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/selective-serotonin-reuptake-inhibitors.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Selective serotonin reuptake inhibitors — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Selective serotonin reuptake inhibitors (Selective serotonin reuptake inhibitors) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Selective serotonin reuptake inhibitor. Area: Psychiatry / Neurology.

marketed Selective serotonin reuptake inhibitor Serotonin transporter (SERT) Psychiatry / Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Selective serotonin reuptake inhibitors (Selective serotonin reuptake inhibitors) — Faculdade de Medicina do ABC. SSRIs block the reuptake of serotonin at the presynaptic neuron, increasing serotonin concentration in the synaptic cleft.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Selective serotonin reuptake inhibitors TARGET	Selective serotonin reuptake inhibitors	Faculdade de Medicina do ABC	marketed	Selective serotonin reuptake inhibitor	Serotonin transporter (SERT)
Lexapro	escitalopram	Generic (originally Lundbeck/Forest)	marketed	Selective Serotonin Reuptake Inhibitor (SSRI)	Serotonin (5-HT) reuptake transporter	2002-08-14
Zoloft	sertraline	Pfizer Inc.	marketed	SSRI (Selective serotonin reuptake inhibitor)	Cytochrome P450 2C19, Melanocortin receptor 5, 5-hydroxytryptamine receptor 2A	1991-12-30
Prozac	fluoxetine	Eli Lilly and Company	marketed	Selective Serotonin Reuptake Inhibitor (SSRI)	Serotonin reuptake transporter	1987-12-29
Track A	Track A	ATS Clinical Research	marketed	Selective serotonin reuptake inhibitor	Serotonin transporter
sertraline fluvoxamine	sertraline fluvoxamine	Second Affiliated Hospital, School of Medicine, Zhejiang University	marketed	Selective serotonin reuptake inhibitor (SSRI)	Serotonin transporter (SERT)
Citalopram HCl	Citalopram HCl	Universitaire Ziekenhuizen KU Leuven	marketed	Selective serotonin reuptake inhibitor (SSRI)	Serotonin transporter (SERT)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Selective serotonin reuptake inhibitor class)

Shanghai Mental Health Center · 2 drugs in this class
ATS Clinical Research · 2 drugs in this class
Faculdade de Medicina do ABC · 1 drug in this class
InnoPharmax Inc. · 1 drug in this class
Istituto Auxologico Italiano · 1 drug in this class
Novartis · 1 drug in this class
Sichuan Baili Pharmaceutical Co., Ltd. · 1 drug in this class
Eurofarma Laboratorios S.A. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Selective serotonin reuptake inhibitors — Competitive Intelligence Brief. https://druglandscape.com/ci/selective-serotonin-reuptake-inhibitors. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab